Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Feb 21;12(3):222.
doi: 10.3390/vaccines12030222.

A Comprehensive Review of Neurodegenerative Manifestations of SARS-CoV-2

Dominika Bedran  1 , Georges Bedran  1 , Sachin Kote  1
Affiliations
Review

A Comprehensive Review of Neurodegenerative Manifestations of SARS-CoV-2

Dominika Bedran et al. Vaccines (Basel). .

Abstract

The World Health Organization reports that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has impacted a staggering 770 million individuals to date. Despite the widespread nature of this viral infection, its precise effects remain largely elusive. This scientific inquiry aims to shed light on the intricate interplay between SARS-CoV-2 infection and the development of neurodegenerative disorders-an affliction that weighs heavily on millions worldwide and stands as the fourth most prevalent cause of mortality. By comprehensively understanding the repercussions of SARS-CoV-2 on neurodegenerative disorders, we strive to unravel critical insights that can potentially shape our approach to the diagnosis, prevention, and treatment of these debilitating conditions. To achieve this goal, we conducted a comprehensive literature review of the scientific data available to date showing that SARS-CoV-2 infection is associated with increased risk and severity of neurodegenerative disorders, as well as altered expression of key genes and pathways involved in their pathogenesis.

Keywords: Alzheimer’s disease; Parkinson’s disease; SARS-CoV-2; brain; dementia; neurodegeneration.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
PRISMA flow diagram.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Serrano-Castro P.J., Estivill-Torrús G., Cabezudo-García P., Reyes-Bueno J.A., Ciano Petersen N., Aguilar-Castillo M.J., Suárez-Pérez J., Jiménez-Hernández M.D., Moya-Molina M.Á., Oliver-Martos B., et al. Influencia de la infección SARS-CoV-2 sobre enfermedades neurodegenerativas y neuropsiquiátricas: ¿una pandemia demorada? Neurología. 2020;35:245–251. doi: 10.1016/j.nrl.2020.04.002. - DOI - PMC - PubMed
    1. Pattanaik A., Bhandarkar B S., Lodha L., Marate S. SARS-CoV-2 and the Nervous System: Current Perspectives. Arch. Virol. 2023;168:171. doi: 10.1007/s00705-023-05801-x. - DOI - PMC - PubMed
    1. Yassin A., Nawaiseh M., Shaban A., Alsherbini K., El-Salem K., Soudah O., Abu-Rub M. Neurological Manifestations and Complications of Coronavirus Disease 2019 (COVID-19): A Systematic Review and Meta-Analysis. BMC Neurol. 2021;21:138. doi: 10.1186/s12883-021-02161-4. - DOI - PMC - PubMed
    1. Jarrahi A., Ahluwalia M., Khodadadi H., Da Silva Lopes Salles E., Kolhe R., Hess D.C., Vale F., Kumar M., Baban B., Vaibhav K., et al. Neurological Consequences of COVID-19: What Have We Learned and Where Do We Go from Here? J. Neuroinflammation. 2020;17:286. doi: 10.1186/s12974-020-01957-4. - DOI - PMC - PubMed
    1. Harrison P.J., Taquet M. Neuropsychiatric Disorders Following SARS-CoV-2 Infection. Brain. 2023;146:2241–2247. doi: 10.1093/brain/awad008. - DOI - PMC - PubMed

LinkOut - more resources